During a recent fireside chat, drug industry disrupter Mark Cuban touted biosimilars and cash pay options as low-hanging fruit for self-insured employers.
Cost Plus Drugs: Biosimilars, Cash Pay Now…
During a recent fireside chat, drug industry disrupter Mark Cuban touted biosimilars and cash pay options as low-hanging fruit for self-insured employers.